NCT00072319View on ClinicalTrials.gov

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

epirubicin hydrochloride

DRUG

paclitaxel

PROCEDURE

adjuvant therapy

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors

Collaborators (2)

Pharmacia
Amgen
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Pharmacia

INDUSTRY

collaborator

Amgen

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER